Gaurav Shah News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Gaurav shah. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Gaurav Shah Today - Breaking & Trending Today

Avoro Capital Advisors LLC Increases Holdings in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)

Avoro Capital Advisors LLC increased its stake in shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Free Report) by 0.9% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 1,260,900 shares of the biotechnology company’s stock after buying an additional 10,900 shares during the quarter. […] ....

New York , United States , William Blair , Gaurav Shah , John Militello , News Ratings For Rocket Pharmaceuticals Daily , Avoro Capital Advisors , Principal Financial Group Inc , Rocket Pharmaceuticals , Rocket Pharmaceuticals Inc , Jpmorgan Chase Co , Cantor Fitzgerald , York State Common Retirement Fund , Rocket Pharmaceuticals Company Profile , Torray Investment Partners , Goldman Sachs Group , Quarter For Rocket Pharmaceuticals , Tower Research Capital , Needham Company , Insider Activity At Rocket Pharmaceuticals , Securities Exchange Commission , Rocket Pharmaceuticals Stock Performance , Free Report , Capital Advisors , Financial Group , Investment Partners ,

Rocket Pharmaceuticals (NASDAQ:RCKT) Announces Quarterly Earnings Results

Rocket Pharmaceuticals (NASDAQ:RCKT) Announces Quarterly Earnings Results
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

Kinnari Patel , Gaurav Shah , Rocket Pharmaceuticals Trading Down , Earnings History For Rocket Pharmaceuticals , Needham Company , Securities Exchange Commission , Rocket Pharmaceuticals , Goldman Sachs Group , Jpmorgan Chase Co , News Ratings For Rocket Pharmaceuticals Daily , Rocket Pharmaceuticals Inc , Get Free Report , Pharmaceuticals Trading Down , Exchange Commission , Rocket Pharmaceuticals Daily ,

Rocket Pharmaceuticals Reports First Quarter 2024 Financial Results and Highlights Recent Progress

Advanced RP-L102 for Fanconi Anemia towards regulatory reviews; EMA accepted MAA for review and BLA submission anticipated in the first half of 2024

Continued preparations to launch LV portfolio. ....

United States , Stanford University , Los Angeles , Agnieszka Czechowicz , Donaldb Kohn , Gaurav Shah , Company Cranbury , Stanford University School Of Medicine , American Society Of Gene , Drug Administration , Rocket Pharmaceuticals , Department Of Pediatrics , Rocket Pharmaceuticals Inc , Treatment Center , Alexion Pharmaceuticals , Division Of Hematology Oncology , University Of California , Arena Pharmaceuticals , Cell Therapy Program , Investor Relations Corporate Communications , Regeneron Pharmaceuticals , Corporate Communications At Krystal Biotech , European Medicines Agency , Liberty Science Center , Fanconi Anemia , Danon Disease ,

China Universal Asset Management Co. Ltd. Buys 8,356 Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)

China Universal Asset Management Co. Ltd. lifted its stake in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Free Report) by 404.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 10,424 shares of the biotechnology company’s stock after buying an additional 8,356 shares during the […] ....

Gaurav Shah , Gotham Makker , Rocket Pharmaceuticals Price Performance , Annandale Capital , Goldman Sachs Group , Jpmorgan Chase Co , China Universal Asset Management Co , Wells Fargo Company , Steward Partners Investment Advisory , Rocket Pharmaceuticals Company Profile , Needham Company , News Ratings For Rocket Pharmaceuticals Daily , Quarter For Rocket Pharmaceuticals , Life Insurance Co , Advisor Group Holdings Inc , Rocket Pharmaceuticals Inc , Rocket Pharmaceuticals , China Universal Asset Management , Free Report , Universal Asset Management , Group Holdings , Partners Investment Advisory , Get Free Report , Director Gotham Makker , Visit Holdingschannel , Rocket Pharmaceuticals Daily ,

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Receives $54.00 Average Price Target from Analysts

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Receives $54.00 Average Price Target from Analysts
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Gotham Makker , Gaurav Shah , Jpmorgan Chase Co , Rocket Pharmaceuticals Stock Performance , Rocket Pharmaceuticals Company Profile , Cantor Fitzgerald , Rocket Pharmaceuticals , Institutional Investors Weigh In On Rocket Pharmaceuticals , News Ratings For Rocket Pharmaceuticals Daily , Goldman Sachs Group , Rocket Pharmaceuticals Inc , Analyst Recommendations For Rocket Pharmaceuticals , Synovus Financial Corp , Metlife Investment Management , Hightower Advisors , Get Free Report , Lifesci Capital , Director Gotham Makker , Tower Advisors , Life Investment Management , Financial Corp , Get Free , Rocket Pharmaceuticals Daily ,